Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY: TEVA )

16.25 -0.38 (-2.29%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,474,924
Open 16.58
Bid (Size) 16.35 (1)
Ask (Size) 16.45 (10)
Prev. Close 16.63
Today's Range 16.08 - 16.63
52wk Range 12.51 - 22.80
Shares Outstanding 1,110,352,397
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Top performing mid-cap stocks last week: WRD (+97.62%), GDS (+43.45%), SWTX (+42.58%), RXRX (+40.59%), SOC (+39.09%), WGS (+28.23%), VNET (+28.22%), NSP (+25.99%), CRSP (+25.21%), AXSM (+24.01%) 
Via Benzinga
This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy?
Via The Motley Fool

Performance

YTD
-23.71%
-23.71%
1 Month
-25.05%
-25.05%
3 Month
-1.46%
-1.46%
6 Month
-11.15%
-11.15%
1 Year
+24.81%
+24.81%

More News

Read More
Spotlight on Teva Pharmaceutical Indus: Analyzing the Surge in Options Activity
Via Benzinga
Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
MarketBeat Week in Review – 02/03 - 02/07
Via MarketBeat
Topics Artificial Intelligence Economy World Trade
Exposures Artificial Intelligence Interest Rates Tariff
Teva Pharmaceutical Indus Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
What Analysts Are Saying About Teva Pharmaceutical Indus Stock
Via Benzinga
Neurocrine Biosciences Reports Mixed Q4
Via The Motley Fool
Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
Via MarketBeat
NVIDIA, Teva Pharmaceutical And UPS Are Among Top Large Cap Losers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Teva Pharmaceutical Stock Is Sinking Today
Via The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Peering Into Teva Pharmaceutical Indus's Recent Short Interest
Via Benzinga
Teva Pharmaceutical Industries (TEVA) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Crude Oil Down 1.5%; Teva Pharmaceutical Shares Plummet
Via Benzinga
Exposures Fossil Fuels
Stocks Tick Down Ahead Of Fed Meeting, Nvidia Jitters Resume, Trump Media Rallies: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy Government
Exposures Interest Rates Political
Stocks Scatter As Investors Prepare For Fed Remarks
Via Talk Markets
Topics Economy Stocks / Equities
Exposures Interest Rates
Nasdaq Down Over 100 Points; Corning Posts Upbeat Earnings
Via Benzinga
Teva Pharmaceutical Posts Lower Revenue. Stock Slips.
Via Investor's Business Daily
Teva Pharmaceutical Stock Falls On Q4 Earnings: What's Going On?
Via Benzinga
Manhattan Associates, LendingClub And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Earnings Scheduled For January 29, 2025
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.